Enovis Corp
ENOV26.290USD
-4.570-14.81%
Fechamento 07/18, 16:00（ET）Cotações atrasadas em 15 min
1.50BValor de mercado
PerdaP/L TTM
Mais detalhes de Enovis Corp Empresa
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Informações da empresa
Código da empresaENOV
Nome da EmpresaEnovis Corp
Data de listagemMay 08, 2008
Fundado em1998
CEOMr. Damien Mcdonald
Número de funcionários7367
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 08
Endereço2711 Centerville Road
CidadeWILMINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal19808
Telefone13022529160
Sitehttps://www.enovis.com/
Código da empresaENOV
Data de listagemMay 08, 2008
Fundado em1998
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
104.51K
+18.11%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
96.30K
--
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
36.11K
+90.73%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+168.36%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+168.36%
Mr. Philip A. Okala
Mr. Philip A. Okala
Independent Director
Independent Director
--
--
Ms. Angela S. Lalor
Ms. Angela S. Lalor
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
104.51K
+18.11%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
96.30K
--
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
36.11K
+90.73%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
International Reconstructive
148.37M
26.55%
U.S. Reconstructive
137.88M
24.67%
U.S. Bracing & Support
115.09M
20.59%
International P&R
90.88M
16.26%
U.S. Other P&R
66.62M
11.92%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
International Reconstructive
148.37M
26.55%
U.S. Reconstructive
137.88M
24.67%
U.S. Bracing & Support
115.09M
20.59%
International P&R
90.88M
16.26%
U.S. Other P&R
66.62M
11.92%
Distribuição de ações
Atualizado em: qui, 10 de jul
Atualizado em: qui, 10 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.64%
American Century Investment Management, Inc.
6.17%
Davenport Asset Management
5.38%
Dimensional Fund Advisors, L.P.
5.12%
Other
61.27%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.64%
American Century Investment Management, Inc.
6.17%
Davenport Asset Management
5.38%
Dimensional Fund Advisors, L.P.
5.12%
Other
61.27%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
46.99%
Investment Advisor
45.59%
Hedge Fund
7.67%
Research Firm
4.24%
Individual Investor
1.55%
Bank and Trust
1.35%
Pension Fund
1.15%
Family Office
0.05%
Sovereign Wealth Fund
0.05%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
630
68.25M
119.48%
-3.27M
2025Q1
646
68.39M
119.73%
-3.70M
2024Q4
637
64.20M
113.02%
-5.55M
2024Q3
613
62.53M
111.92%
-6.94M
2024Q2
617
64.91M
118.38%
-5.04M
2024Q1
651
62.70M
114.40%
-9.13M
2023Q4
661
61.64M
112.95%
-6.99M
2023Q3
653
60.52M
110.96%
-10.76M
2023Q2
641
59.95M
109.96%
-8.07M
2023Q1
643
57.38M
105.33%
-9.99M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
6.52M
11.41%
+1.67M
+34.39%
Mar 31, 2025
The Vanguard Group, Inc.
6.08M
10.64%
-7.15K
-0.12%
Mar 31, 2025
American Century Investment Management, Inc.
3.52M
6.17%
+369.48K
+11.71%
Mar 31, 2025
Davenport Asset Management
3.07M
5.38%
-206.82K
-6.31%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.93M
5.12%
+27.89K
+0.96%
Mar 31, 2025
Royce Investment Partners
2.49M
4.36%
+20.23K
+0.82%
Mar 31, 2025
State Street Global Advisors (US)
1.89M
3.32%
+162.41K
+9.37%
Mar 31, 2025
Diamond Hill Capital Management Inc.
1.87M
3.28%
-918.91K
-32.92%
Mar 31, 2025
Hood River Capital Management LLC
1.44M
2.53%
+781.15K
+118.10%
Mar 31, 2025
River Road Asset Management, LLC
1.39M
2.44%
+153.53K
+12.40%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
SPDR S&P Health Care Equipment ETF
1.7%
Invesco S&P SmallCap Health Care ETF
1.27%
Invesco S&P SmallCap 600 Pure Value ETF
0.53%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
iShares S&P Small-Cap 600 Value ETF
0.29%
SPDR S&P 600 Small Cap Value ETF
0.28%
First Trust Small Cap Growth AlphaDEX Fund
0.28%
iShares U.S. Medical Devices ETF
0.2%
Avantis US Small Cap Equity ETF
0.2%
DFA Dimensional US Small Cap Value ETF
0.18%
Ver Mais
SPDR S&P Health Care Equipment ETF
Proporção1.7%
Invesco S&P SmallCap Health Care ETF
Proporção1.27%
Invesco S&P SmallCap 600 Pure Value ETF
Proporção0.53%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporção0.3%
iShares S&P Small-Cap 600 Value ETF
Proporção0.29%
SPDR S&P 600 Small Cap Value ETF
Proporção0.28%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.28%
iShares U.S. Medical Devices ETF
Proporção0.2%
Avantis US Small Cap Equity ETF
Proporção0.2%
DFA Dimensional US Small Cap Value ETF
Proporção0.18%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Data
Tipo
Proporção
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
